Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHBP | P24387 | 1/20 | 0.53 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.53 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3737938 | 0.98 | CRHBP (0.52) | CRHBPCRHR2 | |
| SCHEMBL4443823 | 0.74 | APEX1 (0.38) | APEX1 | |
| SCHEMBL1994684 | 0.73 | CRHBP (0.63) | CRHBPCRHR2 | |
| Nitric Acid SCHEMBL8647053 | 0.72 | CRHBP (0.57) | CRHBPCRHR2 | |
| SCHEMBL4817167 | 0.70 | APEX1 (0.32) | APEX1 | |
| Methylamine SCHEMBL11565513 | 0.70 | ALDH1A1 (0.31) | — | |
| SCHEMBL23858254 | 0.69 | CYP2D6 (0.31) | — | |
| SCHEMBL4851929 | 0.69 | APEX1 (0.44) | APEX1 | |
| SCHEMBL4583356 | 0.68 | CRHBP (0.47) | CRHBPCRHR2 | |
| SCHEMBL18015997 | 0.68 | CRHBP (0.35) | CRHBPCRHR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8471041-B2 | Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same | ALLIANT TECHSYSTEMS INC. (US) | 2013-06-25 | — | — | US | claimed |
| US-7713401-B2 | Methods for performing electrochemical nitration reactions | BATTELLE ENERGY ALLIANCE, LLC (US) | 2010-05-11 | — | — | US | claimed |
| US-20090038953-A1 | METHODS FOR PERFORMING ELECTROCHEMICAL NITRATION REACTIONS | ENERGY, UNITED STATES DEPARTMENT OF | 2009-02-12 | — | — | US | claimed |
| WO-2009020798-A1 | METHODS FOR PERFORMING ELECTROCHEMICAL NITRATION REACTIONS | BATTELLE ENERGY ALLIANCE, LLC (US) | 2009-02-12 | — | — | WO | claimed |
| US-5336784-A | Synthesis of 1,3,3-trinitroazetidine | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-08-09 | — | — | US | claimed |
| US-12281398-B2 | Microfluidic process for the general electrochemical synthesis of geminal dipseudohalide or halide-pseudohalide compounds | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2025-04-22 | — | — | US | disclosed |
| US-20240293360-A1 | CRYSTALLINE ABDNAZ COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | EPICENTRX, INC. | 2024-09-05 | — | — | US | disclosed |
| CN-118561729-A | Synthetic method and application of nitro cyclic compound | 江南大学 | 2024-08-30 | — | — | CN | disclosed |
| US-20240218528-A1 | Microfluidic Process for the General Electrochemical Synthesis of Geminal Dipseudohalide or Halide-Pseudohalide Compounds | THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE | 2024-07-04 | — | — | US | disclosed |
| EP-4351567-A1 | CRYSTALLINE ABDNAZ COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | EpicentRx, Inc. (US) | 2024-04-17 | — | — | EP | disclosed |
| CN-117835979-A | Crystalline ABDNAZ compositions and methods of making and using the same | 埃皮辛特瑞柯斯公司 | 2024-04-05 | — | — | CN | disclosed |
| US-11926911-B2 | Microfluidic process for the general electrochemical synthesis of geminal dipseudohalide or halide-pseudohalide compounds | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2024-03-12 | — | — | US | disclosed |
| WO-2011100090-A1 | METHODS OF SYNTHESIZING AND ISOLATING N-(BROMOACETYL)-3,3-DINITROAZETIDINE AND A COMPOSITION INCLUDING THE SAME | ALLIANT TECHSYSTEMS INC. (US) | 2011-08-18 | — | — | WO | disclosed |
| US-20110195947-A1 | METHODS OF SYNTHESIZING AND ISOLATING N-(BROMOACETYL)-3,3-DINITROAZETIDINE AND A COMPOSITION INCLUDING THE SAME | ALLIANT TECHSYSTEMS INC. (US) | 2011-08-11 | — | — | US | disclosed |
| US-7829729-B2 | 1-glycidyl-3,3-dinitroazetidine containing explosive moiety and preparation method thereof | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2010-11-09 | — | — | US | disclosed |
| US-7713401-B2 | Methods for performing electrochemical nitration reactions | BATTELLE ENERGY ALLIANCE, LLC (US) | 2010-05-11 | — | — | US | disclosed |
| US-20090299079-A1 | 1-GLYCIDYL-3,3-DINITROAZETIDINE CONTAINING EXPLOSIVE MOIETY AND PREPARATION METHOD THEREOF | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2009-12-03 | — | — | US | disclosed |
| US-20090038953-A1 | METHODS FOR PERFORMING ELECTROCHEMICAL NITRATION REACTIONS | ENERGY, UNITED STATES DEPARTMENT OF | 2009-02-12 | — | — | US | disclosed |
| WO-2009020798-A1 | METHODS FOR PERFORMING ELECTROCHEMICAL NITRATION REACTIONS | BATTELLE ENERGY ALLIANCE, LLC (US) | 2009-02-12 | — | — | WO | disclosed |
| US-5336784-A | Synthesis of 1,3,3-trinitroazetidine | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240293360-A1 | CRYSTALLINE ABDNAZ COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | CRYZ, FASTKD5, DNAJA1 | CRHBP 2505/4885CRHR2 3999/4885APEX1 133/4885 |
| US-20090299079-A1 | 1-GLYCIDYL-3,3-DINITROAZETIDINE CONTAINING EXPLOSIVE MOIETY AND PREPARATION METHOD THEREOF | DNMT1, DNMT3A, HBZ | CRHBP 3060/4885CRHR2 4140/4885APEX1 30/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.